Lucid Diagnostics (NASDAQ: LUCD) revenue
Lucid Diagnostics reported revenue of $4.7m for fiscal 2025, 8.3% more than in fiscal 2024 ($4.3m). Since fiscal 2021 its revenue has grown by 841.2%, an average growth of 75.2% a year.
Lucid Diagnostics has grown its revenue for 3 years in a row, and fiscal 2025 is the highest of its 5 fiscal years on record. The biggest drop was in fiscal 2022, −24.6%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $4.7m | +8.3% | −$49.6m | −1,054.8% |
| 2024 | $4.3m | +79.0% | −$46.1m | −1,059.6% |
| 2023 | $2.4m | +544.0% | −$48.5m | −1,996.8% |
| 2022 | $0.4m | −24.6% | −$56.3m | −14,920.7% |
| 2021 | $0.5m | — | −$27.4m | −5,483.8% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Lucid Diagnostics revenue compared with its sector
By revenue for its latest fiscal year, Lucid Diagnostics ranks 381st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Lucid Diagnostics, 8.3%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 379th | Korro Bio | $6.4m | 181.5% |
| 380th | Abeona Therapeutics | $5.8m | 37.1% |
| 381st | Lucid Diagnostics | $4.7m | 8.3% |
| 382nd | Prime Medicine | $4.6m | 55.3% |
| 383rd | Ocugen | $4.4m | 8.8% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Lucid Diagnostics
- How much revenue did Lucid Diagnostics make in fiscal 2025?
- Lucid Diagnostics reported revenue of $4.7m for fiscal 2025, compared with $4.3m in fiscal 2024.
- How much has the revenue of Lucid Diagnostics grown?
- Between fiscal 2021 and fiscal 2025 it went from $0.5m to $4.7m: 841.2% more, an average growth of 75.2% a year.
- What was the best year for revenue at Lucid Diagnostics?
- Of its last 5 fiscal years, fiscal 2025, with $4.7m.
- Where does Lucid Diagnostics rank in its sector by revenue?
- It ranks 381st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Lucid Diagnostics come from?
- From the annual report (Form 10-K) that Lucid Diagnostics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Lucid Diagnostics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on Lucid Diagnostics: the Lucid Diagnostics page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.